PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 32 filers reported holding PROTARA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,692,594 | $4,496,632 | 1.46% |
| Privium Fund Management (UK) Ltd | 119,730 | $201,146 | 0.16% |
| Ikarian Capital, LLC | 188,664 | $315,069 | 0.04% |
| Orbimed Advisors | 772,584 | $1,290,215 | 0.03% |
| Boxer Capital, LLC | 209,227 | $349,409 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 64,000 | $106,880 | 0.00% |
| Baker Brothers Advisors | 199,671 | $333,451 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 18,864 | $31,503 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 27,345 | $45,666 | 0.00% |
| OSAIC HOLDINGS, INC. | 100 | $167 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 13,821 | $23,081 | 0.00% |
| WELLS FARGO & COMPANY/MN | 565 | $944 | 0.00% |
| NORTHERN TRUST CORP | 20,587 | $34,380 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 78,518 | $131,151 | 0.00% |
| STATE STREET CORP | 30,900 | $51,603 | 0.00% |
| Tower Research Capital LLC (TRC) | 4,794 | $8,006 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 18,047 | $30,138 | 0.00% |
| VANGUARD GROUP INC | 427,612 | $714,112 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 6,314 | $10 | 0.00% |
External links
This page lists PROTARA THERAPEUTICS INC's shareholders in Q3 2023. To view PROTARA THERAPEUTICS INC's shareholder history, click here.